Residual Pockets After Initial Therapy in a Patient With Poorly Controlled Diabetes

Residual probing depths of 6–7 mm are a risk marker, not an automatic surgical indication. The more important findings are the 45% bleeding on probing, the 35% plaque score, and the poorly controlled diabetes. Initial therapy has not yet achieved a stable plaque-control environment, and some of the residual depth may reflect incomplete calculus removal, gingival inflammation, or persistent diabetes-associated inflammation. I would first recheck oral hygiene performance, probe the sites carefully for calculus and restorative overhangs, and assess whether the patient received adequate root instrumentation in the previous course.

Priority one is glycemic control in coordination with her physician, because an HbA1c of 9.1% increases the risk of infection, delayed healing, and recurrence. Priority two is patient-performed plaque control; a 35% plaque score is too high for a surgical or regenerative decision. Priority three is a second, focused course of subgingival instrumentation at the residual sites, with local anesthesia if needed, followed by reevaluation in 6–8 weeks. I would not proceed directly to flap surgery or extraction based on pocket depth alone. If bleeding and depth persist after reinstrumentation and improved hygiene, then surgical access becomes a reasonable next step.

I would explain that no laser has been shown to “sterilize” a periodontal pocket, and current evidence does not support laser therapy as a replacement for scaling and root planing. Lasers may have limited adjunctive effects in some protocols, but the evidence is heterogeneous, and there are risks of thermal damage, expense, and false reassurance. A laser should not be used to avoid needed mechanical therapy or to justify delaying glycemic management.

Local antimicrobials can produce small short-term reductions in probing depth and bleeding, but they do not remove calculus and are not a substitute for instrumentation. They may be considered as an adjunct at a few isolated sites after mechanical therapy, not as the main plan here. Systemic antibiotics are also not automatically indicated for residual pockets. The patient has Grade C periodontitis, but the current limiting factors are poor glycemic control and inadequate plaque control; antibiotics would add resistance risk without correcting those problems. If, after reinstrumentation and improved control, she still has generalized deep bleeding pockets, then adjunctive systemic antibiotics could be reconsidered under the same stewardship principles used for Grade C disease. The sequenced judgment matters more than the product choice.

I would send a concise letter to her physician describing the periodontal infection, the HbA1c of 9.1%, and the planned dental treatment, and ask for optimization of glycemic control. I would not tell her to stop metformin or ramipril. I would explain that periodontal treatment can improve glycemic control modestly, but it is not a substitute for medical management. The physician should know about any planned systemic antibiotics or surgery, and the patient should be counseled about hypoglycemia if her regimen changes.

The dental endpoints before surgical referral are practical: plaque score below 20%, bleeding on probing reduced toward less than 10–20%, residual probing depths generally 4 mm or less, no sites with progressive clinical attachment loss, and stable mobility. I would reassess 6–8 weeks after the second course of instrumentation. If the same 6–7 mm bleeding sites persist despite good compliance and improved glycemic control, I would discuss surgical access, possible regenerative options, and the risks and benefits. If she declines surgery, I would continue frequent maintenance rather than declare failure. The key judgment is to treat the patient's risk profile and behavior before escalating to a procedure.